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Summary
Transgenic mice with a y2b transgene were produced to investigate whether y2b can replace
P in the development of B lymphocytes. Transgenic y2b is present on the surface of B cells.
Young transgenic mice have a dramatic decrease in B cell numbers, however, older mice have
almost normal B cell numbers. Strikingly, all y2b-expressing B cells in the spleen also express
h . The same is true for mice with a hybrid transgene in which the A. transmembrane and
intracytoplasmic sequences replace those of y2b (72b-,umem). The B cell defect is not due to
toxicity of y2b since crosses between y2b transgenic and A transgenic mice have normal numbers
of B cells. Presence of the y2b transgene strongly enhances the feedback inhibition of endogenous
heavychain gene rearrangement. Light chain genes are expressed normally, and the early expression
of transgenic light chains does not improve B cell maturation. When the endogenous A locus
is inactivated, B cells do not develop at all in y2b transgenic mice. The data suggest that y2b
cannot replace A in promoting the developmental maturation of B cells, but that it can cause
feedback inhibition ofheavy chain gene rearrangement. Thus, the signals for heavychain feedback
and B cell maturation appear to be different.
T
he development of B lymphocytes is intimately linked
to the expression of Ig genes (reviewed in reference 1).
Production of membrane-bound IgM is required for B cell
maturation, as mice whose N, gene membrane exons have been
inactivated by targeted recombination lack B cells (2). Fur-
thermore, membrane-bound IgM is required in the control
of the rearrangement of Ig genes by feedback inhibition
(reviewed in reference 3). During B cell development feed-
back inhibition occurs first at the stage of heavy chain gene
rearrangement, followed laterby the cessation of Ig gene rear-
rangement due to the shutoff of V(D)J recombinase. Both
P. and 6 heavy chains can promote feedback inhibition at the
stage of heavy chain gene rearrangement and, in combina-
tion with light chains, at the stage of V(D)J recombinase
shutoff (3, 4) . It is clear from work with transgenic mice
that the membrane form ofp, (Am) is required for both types
of feedback inhibition, and that the secreted form (As) does
not mediate feedback (5, 6). The p, and S proteins have related
transmembrane domains and identical short cytoplasmic tails
(Lys-Val-Lys) (7). The y heavy chains have a similar degree
of homology to P. and 6 in the transmembrane portion, but
have a much longer intracytoplasmic domain (7). All three
heavy chain classes differ considerably in the CH domains.
In light ofthese structural differences, it was ofgreat interest
to compare the effect of y2b in B cell development to that
of A and 6. Presumably, if y2b did not have one or all of
the effects ofA, and S, sequence differences between g./S and
y2b may be implicated in the maturation promoting and/or
feedback effects.
We have produced several different transgenic mouse lines
with a y2b gene, presumably representing different chro-
mosomal insertion sites (8), as well as mice carrying a y2b
transgene whose transmembrane and intracytoplasmic por-
tions have been replaced by those of p, (y2b-Amem). All ex-
press the y2b transgene as shown by tissue-specific y2b RNA
synthesis (8 and not shown). Here we describe the analysis
ofB cells of these transgenic lines in comparison with B cells
from normal littermates and A, transgenic mice.
Materials and Methods
Transgenic Mice.
￿
The343-1and348A y2b transgenic lines have
been described (8). The y2b-Amem transgene, 1241-5-3 (9), was
constructed by ligating the V through the CH3y2b region on
a 10.6-kb PvuI to KpnI fragment that also includes the majority
of pUC13cm, from pVCM to the p, membrane exons contained
on a 2.6-kb KpnI to Pvul fragment from pV167p, (5, 8). The
transgene was isolated as an 11.4-kb Sall to Pvul fragment by gel
electrophoresis and elution from hydroxyapatite (10). The 243-4
p transgenic line used as acontrol has been described(5, 11). The
A transgene encodes both the secreted and membrane forms of is
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The lidelS transgenic line contains a transgene that is a deletion
derivative of theV167A transgene used to generate the 243-4 ji
line . The transgene was derived by deletion of a 1.3-kb Bc1I frag-
ment containing the secreted terminus of the tt gene. This trans-
gene produces only the membrane form of A. The u knockout
line (Amt) was obtained fromK . Rajewsky (University of Koln,
Koln, Germany) viaC. Sidman (University of Cincinnati, Cincin-
nati, OH) . This line contains a disruption of themembrane region
encoding exons of the D heavy chain (2) . The X2 transgenic line
1275-4 contains a functionally rearranged X2 light chain gene from
plasmacytoma MOPC 315 and is regulatedby theheavy chain en-
hancer (12) .
The founder mice of they2b-only mice and the ji and jsdelS
mice were derived from (SJL x C57BL/6)F, and were bred in the
first generation with F, mice. Later generations (for 5-7 yr) were
backcrossed to C57BL/6 . TheA2-andy2b-umem transgenic mice
were produced and propagated in C57BL/6 . The 343-1, 348A,1241-
5-3, and 243-4 lines have the following Brinster designations :
Tg(Igh)Bri49, Tg(Igh)Bri50, Tg(Igh)Bri128, and Tg(Igh)Bri35,
respectively . Their approximate transgenecopy numbers are : 8, 22,
14, and 6, respectively.
Flow Cytometry .
￿
Flow cytometry (FACSO ; Becton Dickinson
&Co., Mountain View, CA)was performed essentially as described
using the following antibodies (12) . Biotinylated rat anti-mouse
CD45R (clone RA3-6132) (PharMingen, San Diego, CA) at 1:100,
PE-conjugated monoclonal rat anti-mouse K (Becton Dickinson
&Co .) at 1:50, FITC-conjugated goat anti-mousey2b(GAMy2b;
Southern Biotechnology Assoc., Birmingham, AL) at 1:100, PE-
conjugated GAMji(SouthernBiotechnology Assoc.) at 1:100, PE-
conjugated Streptavidin (Jackson ImmunoResearch Labs ., Inc., West
Grove, PA) at 1:80, FITC-conjugated or biotinylated mouse
anti-mouse IgH-6a (IA4), cloneDS-1 at 1:100 (kindly provided by
Dr.JimKenny, Frederick Cancer Center, Frederick, MD), and bi-
otinylated mouse anti-mouse IgH6b (jib), clone AF6-78 at 1:100
(PharMingen) . Samples were analyzed by FACScana using
Consort30, FACScan0, or LYSIS software (Becton Dickinson &
Co.) . A total of 104 lymphocytes as determined by forward and
side scatterwere analyzed per sample. Where indicated, dead cells
were excluded using propidium iodide staining. Just before anal-
ysis, 10-20 jil of 1 mg/mlpropidium iodide (Sigma ChemicalCo.,
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Figure 1 .
￿
Schematic representa-
tion of y2b (A) and y2b-umem
transgene constructs (B).The trans-
gene constructs aredrawn approxi-
mately to scale. Filled boxes repre-
sent exons, the filled oval represents
the heavy chain enhancer, and the
boxes at the ends indicate pUC13
vector sequence. B, BamHI ; E,
EcoRl ; K, KpnI ; P, Pvul . (A)y2b
transgene. (B) y2b-14mem hybrid
transgene. Striped boxes and dotted
lineindicate region derived from the
ti locus.
St. Louis, MO)was added to each sample. In these cases, the data
collection gate was set on live cells and was regated on lympho-
cytes upon analysis .
Ribonuclease Protection.
￿
Ribonuclease protection assay (RDAs)'
were performed using the RPA and RPAII kits (Ambion Inc.,
Austin, TX) according to the manufacturer's instructions . Briefly,
10-30 Iig of sample RNA plus yeast tRNA to give a total of 30
jig ofRNA was hybridized overnight (>8 h) with 2 x 105 cpm
ofeach probe in a 20-jil reaction volume at 53°C. RNase digestion
was carried out at 30°C using a 1:100 dilution of solution R
(RNaseA and Ti) followed by resolution of protected fragments
on 5% denaturing acrylamide/urea gels. The T, /3-Act plasmid
(Ambion Inc.) contains a 250-bp KpnI to Xbal fragment from
pAL41 (13) in the USB vector pT,-1. Restriction with Ddel and
in vitro transcription using T, RNA polymerase results in a 160-
nucleotide (nt) protected fragment in RPA . TheCH3MA probe
was generatedby cloning the 458-bp Accl to Mscl fragment con-
tainingy2bCH3 andpoly(A) signal for the secreted y2b message
into theSmal site of BluescriptKS+. Linearization with Xbal and
in vivo transcription with T3RNApolymerase generates a -548-
nt transcript that protects 404-nt secreted y2b and 297-nt mem-
braney2b fragments in RPA (see Fig. 3) . TheCH4AH probewas
generatedby cloning the 726-bp ApaLI to HindIII fragment, in-
cluding,uCH4, the secreted 1i terminus, and poly(A) signal into
BluescriptKS + . Linearization withBamHI and in vitro transcrip-
tion usingT3 RNA polymerase protects a 519-nt secreted ji frag-
ment anda333-nt membrane A fragment in RYA . TheCK-2 probe
was generated by PCR amplification of a 625-bp fragment con-
taining the last 307 by of theJ-CK intron and the first 318 by o£
the CK exon (essentially the whole coding region) . The fragment
was cloned into the SmaI site of Bluescript KS+ (Stratagene, La
Jolla, CA), and antisense CK transcripts are generated by lineariza-
tion with BamHI and transcription using T3 RNA polymerase.
Processed CK mRNAs result in a 318-nt protected fragment .
i Abbreviations used in this paper: M, membrane; nt, nucleotides; RPA,
ribonuclease protection assay.Results
Splenic B Lymphocytes at Different Ages.
￿
The results from
two transgenic lines carrying a functionally rearranged y2b
transgene and one line containing a hybrid y2b-F,mem trans-
gene are reported here. Fig. 1 shows a scheme of each trans-
gene construct.
Splenic lymphocytes from littermate or age-matched normal
and y2b transgenic mice were analyzed by FRCS® in order
to compare their B cell populations. Neonatal mice from the
y2b 343 line have very few B cells. Less then 1% of splenic
lymphocytes are either A or K positive compared with 11-12%
in normal littermates (Table 1). 2-wk-old y2b-lmem trans-
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genic mice have a similar defect (data not shown). At 4 wk
of age, the y2b transgenic lines have a significantly lower
percentage of «+ or w+ (mIg+) cells compared with normal
mice or with A. transgenic mice. The defect is most severe
in the 343 line, which has only 11% A.+ cells compared with
54% in normal mice (Table 1) . The percentage of
K+ cells
matches that of it, indicating that there are essentially no
B cells that express y2b without also expressing /A. Surpris-
ingly, when the transmembrane and intracytoplasmic portion
ofA. is substituted for that of y2b, the resulting y2b-I.mem
transgenic mice have the same phenotypes as y2b transgenic
Cells were stained for the indicated markers and analyzed by FASCcang. A total of 104 lymphocytes as defined by forward scatter and side scatter
were analyzed per sample. The average percentage of lymphocytes positive for the given marker is indicated at a 90% confidence level as determined by t test.
' Average number of nucleated spleen cells. Range of values is in parenthesis.
t Ft transgenics were analyzed using allotype-specific antibodies. end, endogenous 0; trg, transgenic pa.
Table 1. Flow Cytometric Analysis of Splenic Bone Marrow B Cells
No. of spleen
Mouse Type tc W y2b cells"
x 10,
Spleen of Normal (n = 7) 12.5 ± 3.0 11 .5 ± 2.1 2.3 ± 1 .2 8.5 (3.8-13.2)
6-d-old
mice
343-1 (n = 2) 0.2 ± 0.3 0.25 ± 0.5 1.0 ± 0.3 8.6 (7.2-10.0)
y2b
B220
Spleen of Normal (n = 13) 56.1 ± 1.8 54.2 ± 2.9 3.05 ± 1 .5 64.3 ± 2.5 51 (39-90)
4-wk-old
mice
343-1 (n = 9) 11.7 ± 2.7 11.4 ± 2.2 14 .5 ± 4.3 25.6 ± 1.8 16 (10-27)
y2b
348A (n = 2) 39.8 ± 7.3 35.6 ± 3.8 5.1 ± 3 .8 44.4 ± 0.6 25 (23-27)
y2b
1241-5-3 (n = 5) 16.0 ± 3.8 16.8 ± 3.9 15 .7 ± 3 .4 44.3 ± 7 .2 19 (16-22)
y2b-lmem
243-4 (n = 4) 49.8 ± 2.1 28.8 ± 7.4 2 .4 ± 0.4 52.6 ± 4 .4 42 (31-56)
Ft (end)
28.8 ± 10.8
(trg)
B2201° B220h'gh
Bone marrow Normal (n = 5) 51 .1 t 3.8 50.5 ± 5.3 10.3 ± 4.2 51 .3 ± 8.4 30.3 ± 7.6
cells of
adult mice#
343-1 (n = 5) 18.2 ± 8.7 21.0 ± 10.7 11.1 t 1 .8 47.8 ± 18.3 11.2 ± 7.5
y2bmice (Table 1) . In contrast, in p, transgenic mice, the per-
centage of K+ cells is greater than endogenous p, , indicating
that -21% B cells express transgenic p. without endogenous
h (Table 1) (5, 14, 15) .
By 16 wk, B cells in the y2b mice have increased to near
normal numbers (not shown) . But, unlike in p. and S trans-
genic mice (5, 6, 16), B cells of the y2b mice always coex-
pressy2b and endogenous p. (Fig . 2) . Again, the y2b-p.mem
transgenic mice have the same phenotype as y2b transgenics
(Fig. 2) . In the 343 y2b and y2b-p.mem lines virtually all
B cells coexpress u andy2b. In the348A line, a large propor-
tion of p+ B cells are -y2b1° or y2b - . It is not known
whether in these cells the transgene has been inactivated or
whether the endogenous u H chain preferentially associates
with the L chain that happens to be produced by these cells.
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Figure 2 . Two-color FRCS®
analysis ofsplenic lymphocytes from
adult y2b mice . p-PE staining on
the y-axis and y2b-FITC staining
on the x-axis are shown for repre-
sentative 343 y2b, 348A y2b, and
y2b-pmem transgenic mice, each
in comparison with a normal lit-
termate .
Thus, splenic B cells from y2b mice coexpress p, on all
-y2b+ cells. The replacement of the y2b transmembrane and
intracytoplasmic regions with those of to is not sufficient to
permit the development ofy2b-onlyB cells. In addition, y2b
andy2b-pmem mice are defective in the formation ofB cells,
as revealed by the low B cell numbers in young mice . This
defect is overcome with age and the severity of the defect
varies among transgenic lines. Preliminary analysis of two
additional y2b transgenic lines agrees with these findings (not
shown) .
The y2b Transgene Is ExpressedEarly and atHigh Levels during
FetalDevelopment. Analysis of lymphoid bonemarrow cul-
tures and Abelson murine leukemia virus-transformed bone
marrow pre-B cells indicated that the 343 mice express y2b
in the pre-B compartment (17) . This implies that the trans-2011
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Figure 3 .
￿
RPA of fetal liver and adult
bonemarrowRNAs . (A andB) Schematic
representation of u and y2b probes for
RPA. The indicated regions were cloned
into the Bluescript KS + vector in order to
generate in vitro transcripts specific for the
/.t or y2b isotypes . Exons are represented
by boxes ; TGA indicates the termination
codon for the secreted form ofthe indicated
Ig ; the site of the poly-adenylation signal
is indicated, as are splicedonor sites for the
membrane specificform ofthemRNA. The
predicted region of identity between the
cloned region and the membrane vs. secreted
forms of the Ig mRNA are shown . (A)
ft-specific probe covering theCH4 exon and
the 1L-secreted tail . (B) y2b-specific probe
coveringtheCH3 exon andpoly(A) region
ofsecretedy2b. (In contrast to fit, y2b does
not contain a specific secreted terminus .)
(C-E) Approximately 30 jig of total cel-
lular RNA from individual fetal livers (C
and E) or 10 ug from adult bone marrow
(D) were analyzed byRPA for expression
ofy2b and ti (C and D) or K (E). (C) Day
12 and 13 fetal liver expression ofthemem-
brane and secreted specific forms of they2b
and AmRNAs areindicated . Each lane con-
tainsmRNA from one individual fetus of
either normal (NML) or y2b (343) trans-
genic genotype. Lane 5 of the 13-d experi-
ment shows traces of sample carried over
from lane 4 . (D) it and y2b expression in
individual samples of adult bone marrow
from normal or 343 y2b transgenic mice
is indicated. (E) Day 13 or 17 fetal liver ex-
pression ofCu in individual normal or 343
y2b fetuses is indicated. In all cases /3-actin
expression served as a control for RNA
loading in order to facilitate comparisonbe-
tween lanes . Labeled 123-nt ladder or
pBR322 cut with Mspl served as size
markers .B
L
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Figure 4.
￿
FACS® analysis of bone marrow from 343 y2b transgenic and normal mice. (A) Anti B220 (top) and anti K (bottom) staining. The x-axis
indicates the fluorescence intensity ofstaining for the indicated marker using PE-coupled antibodies. The y-axis indicates the number of bone marrow
lymphocytes positive for each level of staining with the indicated marker. Blackened area, 343 y2b transgenic; outlined area, normal mouse. (B) B220o
bone marrow lymphocytes of 343 y2b mice. B2201o, mlg - bone marrow cells reanalyzed for cell size by forward scatter are indicated by histograms.
The percentage of large, less mature cells is indicated in the right-hand region of each panel. The percentage of smaller, more mature cells is indicated
in the left-hand region. Three individual adult 343 y2b mice are shown each in comparison with a normal littermate.
gene is expressed appropriately to mediate allelic exclusion,
namely around the time of the first ft expression when de-
veloping B cells are beginning to rearrange their endogenous
H chain genes (18, 19, 20). In light of the observed lack of
allellic exclusion in mature cells described above, we sought
to define more precisely the stage at which the y2b gene is
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first expressed. We used an RPA for analysis of fetal liver
(Fig. 3), because B cell development occurs in a synchronous
wave in this organ (20). Individual fetal livers at days 12, 13,
15, and 17 of gestation were analyzed. Expression of y2b
is readily detectable and several-fold higher than that of la
in day 12 fetal liver from 343 y2b transgenic mice (Fig. 3C). Both membrane and secreted y2b mRNAs are produced,
although the level of secreted mRNA exceeds that of mem-
brane mRNA (Fig. 3 C). This prevalence of secreted y2b
mRNA is in agreement with data that show an excess of
secreted over membrane y2b mRNA in lymphoma and my-
eloma lines (21, 22). The level of y2b expression increases
through day 17 (days 15 and 17 not shown).
The data indicate that the y2b transgene is expressed at
an appropriate developmental point to mediate allelic exclu-
sion, namely during the time of endogenous H gene rear-
rangement. The levels of membrane y2b are approximately
equivalent to or higher than membrane u levels at every time
point. In light of these findings, the lack of H gene allelic
exclusion seen in the peripheral B cells ofy2b transgenic mice
does not appear to be due to insufficient or delayed expres-
sion of membrane y2b.
The Bone Marrow Compartment Reveals a Block in B Cell
Development in y2b Transgenic Mice. To assess the stage at
which B cell development is inhibited in y2b transgenic mice,
cells of the B cell lineage were analyzed in the bone marrow.
FACS® analysis of bone marrow from normal and 343 y2b
mice shows two B220 populations (Fig. 4 A and Table 1).
In normal mice, the B22010 population comprises 51% of
the lymphoid compartment in bone marrow and the B220h'
population comprises 30% (Table 1). However, in the bone
marrow of 343 y2b transgenic mice the B220h` population
is decreased to only 11% of the lymphoid cells (Table 1). In
addition, in normal mice, 50% of the bone marrow lym-
phoid cells express IgM on the cell membrane (mIgM) while
only 18% of 343 bone marrow lymphoid cells are mIg posi-
tive as indicated by K staining (Fig. 4 A and Table 1) . As
in the spleen, all 343 bone marrow cells that are y2b positive
are also u positive (data not shown). While few cells in 343
bone marrow express mIg at the cell surface, mRNA for mem-
brane y2b readily can be detected (Fig. 3 D).
In both normal and 343 y2b bone marrow, all B220h' cells
are also mIg+, while the B22010 population consists of both
mIg - and mIg+ populations representing pre-B and B cells,
respectively. In addition, the B2201°, mIg - population con-
tainsboth large and small pre-B cells that can be distinguished
based on forward light scatter. In normal mice, 69-80% of
the B2201° pre-B cells are the small more mature type, while
only 44-56% of 343 y2b transgenic B22010 pre-B cells are
of this type (Fig. 4 B) .
The data suggest that the paucity of B cells observed in
the spleens ofyounger y2b mice may result from an inefficiency
in generating B cells. This defect manifests itselfin the bone
marrow as a decrease in the B220P population. It appears
that the block in B cell development may occur within the
B22010 pre-B cell compartment, which is skewed to contain
a greater proportion oflarger, less mature cells. The data imply
that y2b transgenic mice are not able to generate small pre-B
(and subsequently B cells) as efficiently as normal mice. All
the B220h' cells that emerge in y2b transgenic bone marrow
express 1., thus implying that 1, may be required for this step
of B cell development and that y2b cannot function as a sub-
stitute.
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y2bExpression Is Not Toxic to B Cells, butIt Inhibits Heavy
Chain Gene Rearrangement. The high levels of expression
of y2b in the 343 fetal liver and bone marrow and the dra-
matic decrease in the population of more mature B220h' cells
in y2b transgenic mice raised the possibility that the y2b
transgenic heavy chain is toxic to developing B cells. Alter-
natively, y2b may not be able to provide certain physiolog-
ical signals that are essential for development. To distinguish
between these alternatives, a functional w transgene (from
mouse line 243-4) was crossed into the 343 y2b transgenic
background.
Similar to previous findings, 7-wk-old 343 y2b mice ex-
hibit a dramatic decrease in splenic B cells (Table 2). The 243-4
1. transgenic mice, on the other hand, have almost normal
numbers of B cells. Crossing the y2b transgenic mice with
the p, transgenic mice leads to a reversal of the B cell defect
characteristic of y2b transgenic mice. There is a considerable
increase in the population of B220+ and
K+ cells in y2b x
p. double transgenic mice at both 7 and 16 wk in comparison
with the 343 y2b only littermates (Table 2) . These findings
suggest that the y2b transgene product itself is not inhibi-
tory to B cell development in the presence of a functional
chain.
The Ic transgenic mice show little feedback inhibition of
endogenous IC.genes. These t, transgenic mice have few trans-
genic u-only cells, but endogenous 1A-only and endogenous
Ic plus transgenic I,-positive B cells represent the majority
of B cells in the spleen of the 1, transgenic mice (Fig. 5 A).
There is a striking decrease in the percentage of cells expressing
endogenous u in the double transgenic mice in comparison
with transgenic /A-only mice (Fig. 5 A), showing that y2b
strongly inhibits endogenous H gene rearrangement. How-
ever, all the y2b expressing cells also coexpress transgenic
p. (Fig. 5 B).
Thus, the y2b protein does not act in a dominant manner
to disrupt B cell development. The exclusion of endogenous
A gene expression in y2b+/1A+ double transgenic B cells re-
veals a pronounced rearrangement feedback effect by the y2b
transgene. The feedback presumably occurs through inhibi-
tion of heavychain gene rearrangement and does not impede
the expression of the t, transgene.
The feedback effect by y2b is further demonstrated in hy-
bridomas from y2b transgenic mice (Table 3). Only 18%
ofhybridomas from normal mice have either a germline heavy
chain or a DJ rearrangement on one of the heavy chain al-
leles. However, 59% of y2b transgenic hybridomas have an
unrearranged or incompletely rearranged heavy chain allele.
Expression ofa Transgenic Light Chain Does Not ImproveB
Cell Development in y2b Transgenic Mice. The data suggest
a functional inadequacy of y2b compared with W during B
cell development. One characteristic attributed to heavychain
expression is the induction oflight chain gene rearrangement
(23). To test the possibility that the defect in B cell develop-
ment characteristic of y2b transgene expression is due to an
inability to induce light chain gene expression and rearrange-
ment, the 343 y2b line was crossed to the 1275-4 X2 trans-
genic line. This transgene causes partial feedback on bothSpleen cells from offspring of 343-1 y2b x 243-4 Ft crosses were stained for the indicated markers and analyzed by FACScan®. A total of 104 lym-
phocytes as definedby forward scatter and side scatter were analyzed per sample. The percentage of splenic lymphocytes from each animal positive
for the given marker is indicated.
* Et expression was analyzed using allotype-specific antibodies. Ab, endogenous a; IA-, transgenic u.
t No mice without a transgene were present in this litter.
H and L chain gene rearrangement, presumably because it
is expressed in early pre-B cells due to the presence of the
heavy chain enhancer (12).
Table 4 summarizes the analysis of (343 y2b x 1275-4
X2) offspring from three independent experiments. As be-
fore, 343 y2b transgenic spleen cells express A and x as well
as y2b. The percentage of X+ cells in 343 transgenic spleen
is 5%, equivalent to that in normal mice. Similar to previous
results (12), the X2 transgenic mice express X on 33% of splenic
lymphocytes and K on 26%. In double transgenic y2b x
X2 offspring the percentage of X expression is increased com-
pared with y2b-only mice. Many cellscoexpress Kand A (not
shown). Compared to y2b transgenic mice the numbers of
Ig+ B cells do not increase. Again, all the B cells that
emerge in the spleen express u, and most also express y2b.
Thus, the presence of a functionally rearranged light chain
expressed early in B cell development does not result in the
repair of the B cell depletion or the production of B cells
expressing the y2b transgene alone.
Induction of K Transcription during Fetal Development Is
Normal.
￿
To further analyze a possible effect of they2b trans-
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gene on light chain expression, we determined the levels of
K mRNA in fetal livers ofy2b mice in comparisonwith normal
littermates. Using RPA analysis we examined Ctc transcripts
at days 13, 15, and 17 of gestation. The probe used in these
studies detects but does not distinguish between rearranged
and germline tc transcripts (see Materials and Methods) . At
day 13, K transcripts are barely detectable in both normal and
343 y2b transgenic fetal liver (Fig. 3 E). By days 15 (not
shown) and 17 (Fig. 3 E), the levels oftc expression have sub-
stantially increased. However, no differences are seen in the
relative levels ofKexpression between normal and y2b trans-
genic mice at any time.
The findings indicate that normal mice do not initiate tc
transcription earlier nor to a higher level at any of the time
points analyzed in comparison to y2b transgenic mice. Since
a correlation exists between the rate of transcription at the
Klocus and the rearrangement of K genes (24), no significant
differences in K gene rearrangement are likely to be occuring
normal vs. y2b mice. Thus, the defect in B cell development
characteristic ofy2b transgenic mice does not seem to result
from a failure to induce light chain production.
Table 2. Flow Cytometric Analysis of Splenic B
Mouse Type
Cellsfrom
K
343-1 y2b crossed
w,*
to 243-4 it Mice
b* y2b B220
7 wk# 243-4 47 25 31 2 48
51 43 47 2 57
51 27 43 2 52
50 41 33 3 53
343-1 13 5 16 13 25
y2b 16 4 18 16 28
17 8 17 17 24
343-1 y2b 40 39 11 17 41
X 28 28 12 27 31
243-4 A 49 47 8 15 N.D.
16 wk Normal 61 2 60 5 72
68 1 66 5 71
243-4 61 29 44 5 71
h 66 39 52 5 72
343-1 30 6 31 31 57
y2b 28 6 32 21 54
343-1 y2b 53 53 10 49 70
X 49 41 16 41 56
243-4 1. 56 53 11 47 62A
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Figure 5.
￿
343 -y2b x 243-4 W transgenic mice. (A) Endogenous Fr and transgenic p staining of splenic lymphocytes: endogenous W (pb-PE) on
the y-axis and transgenic u (,a-FITC) on the x-axis. The genotypes are indicated. (B) Transgenic Ft and y2b staining on splenic lymphocytes. Trans-
genic W expression is shown on the y-axis and transgenic -y2b-FITC expression on the x-axis. The mice were 16 wk old.
No Mature B Cells Develop in y2b Transgenic Mice in the
Absenceofa FunctionalEndogenous A Locus. The production
of membrane-bound H chain is an absolute requirement for
B cell development (2). To test the hypothesis that y2b cannot
promote B cell development beyond the pre-B cell stage, 343
y2b transgenicmice were crossed to p knockout mice. Spleen
and bone marrow from the offspring of these crosses were
analyzed at 8 wk of age for expression of B220 and mIg
(Fig. 6).
Nontransgenic mice heterozygous for the disruption of the
A membrane domain express B220 and K on 47% of splenic
lymphocytes (Ty2b-, Am+/-; Fig. 6 A). In comparison,
only a background staining of N1% positive cells is seen in
homozygous w knockout mice (Ty2b-, Am- /-). Homozy-
gous is knockout mice also expressing the y2b transgene
(Ty2b+, Am-/-) do not produce ic-expressing B cells and
are phenotypically similar to nontransgenic A knockout mice
(Ty2b-, p.m-/- ). Thus, the presence ofthe y2b transgene
does not allow the rescue ofB cells in the absence ofmembrane-
bound IA. Heterozygous h knockout, y2b transgenic mice,
however, are able to produce splenic B cells (Ty2b+, Am+/- ;
Fig. 6 A).
As expected, the bone marrow of the y2b -/- ; Am -/-
mice contains only B22010 cells (Fig. 6 B), but also in y2b
transgenic mice, regardless of the p. genotype, very few
B220h' cells are seen in the bone marrow (Fig. 6 B). This
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is consistent with the failure to produce B cells in the pres-
ence of the y2b transgene. These cells are lower in numbers
than in the analysis shown in Table 1, presumably because
the mice in Fig. 6 B are younger (see Discussion).
As a control, we performed a similar analysis using a p.
transgenic line, p.delS. This transgenic line expresses only the
membrane form of p,, and exhibits efficient B cell develop-
ment and feedback inhibition of endogenous A expression
(Fig. 6 C, Kim, J. Y and P. Roth, unpublished results). In
the absence of a functional endogenous A locus, pdelS trans-
genic mice (AdelS+ ; Am -/-) retain the ability to produce
a normal composition of splenic lymphocytes (Fig. 6 C). Thus,
the peripheral B cell population can be reconstituted with
a single type of heavy chain molecules.
From the analysis of these y2b and y2b-pmem mice, we
conclude that the y2b heavy chain cannot functionally sub-
stitute for 14 in all aspects of B cell development. While y2b
or y2b-Amem are able to mediate feedback inhibition ofen-
dogenous H gene rearrangement, they do not promote matu-
ration or survival of B cells.
B Cell Development Is Blocked at an Early, Pre-B Cell Stage
in y2b Transgenic Mice The bone marrow ofy2b transgenic
mice shows a marked decrease in the B220h' population.Table 3.
￿
IgH Rearrangement and Ig Secretion in y2b
Transgenic and Normal Hybridomas
8 j,, 10 y2b
1 y2b
2 Ft, 1 y2b
Hybridomas were generated from splenic LPS blasts of 4-wk-old mice.
Culture supernatants were screened in an ELISAfor thepresence of secreted
Ig. DNA was analyzed by Southern blots for IgH rearrangement.
" Configuration of detectable H genes. G, germline; DJ, D to J rear-
rangement; VDJ, V to D toJrearrangement. In caseswhereonly a sin-
gleallele is indicated, the other allele couldeither have been lost or gives
an indistinguishable pattern on Southern blots.
t Number of hybridomas containing the indicated gene configurations.
S Secreted Ig detected in hybridoma culture supernatant by isotype-
specific ELISA.
II Threehybridomas that did not secrete Ig were excluded from the cal-
culation ofpercentages sinceit is notknownif they mayhave arisen from
pre-B cells.
Spleen cells from offspring of 343-1 y2b x 1275-4 X2 crosses were stained for the indicated markers and analyzed by FACScano. The data are an
average of threeexperiments. A total of 104 lymphocytes as definedby forward scatter and side scatter were analyzed per sample in one experiment.
In theothertwoexperiments, propidiumiodide wasused to eliminatedead cells. Theanalysis was then regated on lymphocytes . The averagepercen-
tage of splenic lymphocytes positive for the given marker is indicated at a 90% confidence interval as determined by t test.
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This population contains both recirculating and newly pro-
duced B cells that express mIg (25, 26). The B220hi cells
that are present in y2b transgenic bone marrow exhibit an
identicalphenotypeas peripheral splenic B cellsfrom the same
mice. All the y2b+ cells also coexpress endogenous p. at the
cell surface. This is an important observation because it indi-
cates that y2b-only B cells are not produced.
In contrast to the defect in the B220h' population, theper-
centage of cells in the immature B22010 population appears
relatively normal, however, thedistribution ofcell sizes within
this pre-B cell compartment is skewed towards larger, less
mature cells in y2b transgenic bone marrow (Table 1 and
Fig. 4 B) . Large, B22010 early preB cells have begun to rear-
range D to J genes at the H loci; these cells transit to the
next preB stage and become small, B2201°, noncycling cells
with rearranged VDJ genes and germline K genes (26-28).
In the normal developmentpathway, the transition from large
to small B22010 pre B cells is concomitant with the decrease
of CD43 and the acquisition ofcytoplasmic p, expression (26,
27). This latter population is decreased in y2btransgenic mice
similar to mice with homozygous deletion of the X5 gene
or the u membrane gene segment (2, 29, 30). The implica-
tion is that y2btransgenic mice arenot able to generate small,
late stage, pre-B cells as efficiently as normal mice, and sub-
sequently exhibit a depletion of later stages of B220h' bone
marrow and splenic B cells.
A Modelfor B CellDevelopment in y2b Transgenic Mice.
￿
We
propose a model for B cell development in y2b transgenic
mice in which the majority of B cell precursors developing
in the bone marrow express high levels of y2b early in the
developmental pathway (Fig. 7). In developing pre-B cells
they2b transgene product causes cessation offurtherHgene
rearrangement. This effect is similar to that of endogenous
,u chains and transgenic A or 6 chains. After this point, the
function of y2b diverges from Ft in this model. Large,
B2201° pre-B cells seem to require a signal generated pri-
Table 4. FLow
Mouse type
Cytometric Analysis ofSplenic B Cells from 343-1 y2b Crossed to 1275-4 112 Mice
y2b B220
Normal 45.6 ± 5.9 4.8 ± 3.0 48.0 ± 6.0 8.7 ± 5.4 47.1 ± 9.4
(n = 9)
343-1 y2b 17.4 ± 7.1 4.9 ± 1.7 20.8 ± 7.4 11.9 ± 2.4 29.0 t 2.1
(n = 8)
1275-4 X2 25.6 ± 6.8 33.0 ± 7.4 33.1 t 6.4 7.7 ± 1.6 30.7 ± 10.0
(n = 8)
343-1 y2b
X1275-4X2 10.8±5.4 16.0±4.6 20.5 ± 4.0 14.7 ± 2.3 29.7 ± 1.0
(n = 11)
H genes" No.t
y2b transgenic hybridomas
Percent Secreted Ig
G 6(9)11 22 6 y2b, 3 none
DJ/DJ 0
VDJ 8 30 6 u and y2b, 1 y2b, 1 t
VDJ/G 1 4 1 u and y2b
VDJ/DJ 9 33 8 ft and y2b, 1 y2b
VDJ/VDJ 3 11 3 It and y2b
Normal mouse hybridomas
No. Percent Secreted Ig
G 0
DJ/DJ
VDJ
0
18 82
VDJ/G 1 4
VDJ/DJ 3 14
VDJ/VDJ 02017
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Figure 6 .
￿
FRCS® analysis of 343 -y2b x jt knockout mice (A and B)
and A x p, knockout mice (C) . Plots depict expression on splenic (A and
C) or bone marrow (B) lymphocytes . (A andB) B220-FITC on thex-axis
and a"PE on the y-axis . (C) Total A-PE (R' + pb) on the y-axis and trans-
genic u-FITC (A~only) on the x-axis. The genotypes are indicated. T-y2b,
transgenic y2b ; Tp,de1S, transgenic Ade1S ; pm+/- , endogenous p mem-
brane exon wild-type/disrupted .DrOB--___, early
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marily via the pre-B cell receptor in order to progress to be-
come small B2201d late pre-B cells (2, 29, 30). Expression
of membrane p is apparently required for this transition. The
failure ofy2b to generate this survival or differentiation signal,
in combination with the reduction of rearrangement at the
endogenous H gene loci, results in the B cell defect charac-
teristic of y2b transgenic mice.
In rare pre-B cells of y2b transgenic mice, endogenous H
gene rearrangement proceeds to completion. This could be
due to lower levels or later timing of expression of the y2b
gene in a small number of cells, or to early rearrangement
events proceedingbefore y2b heavychain signals stop H gene
rearrangement. If the endogenous rearrangement is in frame,
a functional a heavychain will beproduced in the developing
cell. This cell will then receive the required survival or differen-
tiation signals via its endogenous u chain and will proceed
through further development. Such cells must be very rare,
since it takes >16 wk to achieve normal B cell levels in the
spleen when the mice have a wild-type g locus (Tables 1 and 2).
The frequency with which this rare event of endogenous
H gene rearrangement occurs seems to vary among trans-
genic lines. The 343 y2b line shows the most severe deple-
tion ofB cells, while the 348A y2b line exhibits only a modest
depletion in B cell number. Presumably the variation in the
B cell defect results from variation in levels and timing of
transgene expression during B cell development due to in-
tegration site effects. Thus, compared with the other lines,
the 343 line may express the y2b transgene earlier (and more
strongly), causing a greatly delayed accumulation of P+
cells. Conversely, the 348A line, which shows very low
numbers of y2b+ splenic B cells, may express y2b at too
low a level in many pre-B cells to cause suppression of en-
dogenous H gene rearrangement.
Possible toxicity of the y2b transgene has been shown to
be unlikely by crossing a functional ju transgene into y2b
transgenic mice (Table 2). This leads to a reversal of the B
cell defect, indicating that y2b expression does not curtail
B cell development when a P. chain is present.
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Figure 7.
￿
Model of B cell development in y2b trans-
genic mice. The model outlines the inhibition of Ig gene
rearrangement mediated by y2b during the pro-B through
early pre-B cell stages. B cell development arrests before
the late pre-B cell stage resulting in a general B cell defect
in y2b transgenic mice. Rare cells arise that rearrange en-
dogenous heavy chain genes, and these cells can progress
through the complete developmental pathway to give rise
to mature splenic lymphocytes.
The data argue that the failure to produce y-only mature
B cells in y2b transgenic mice does not result from a failure
of y2b to inhibit feedback ofendogenous H gene rearrange-
ment. On the contrary, a striking decrease in endogenous
,u expression occurs in y2b x A double transgenic mice com-
pared with P transgenics. Analysis of spleen B cell hybrid-
omas further confirms that y2b promotes strong feedback
inhibition of H gene rearrangement.
As conclusive test for the proposed model of B cell devel-
opment in y2b transgenic mice, the 343 y2b line was crossed
with the /,mem knockout line. If our model is correct, in
the absence ofa functional P. chain, no peripheralB cells should
be produced in 343 y2b mice homozygous for the FAmem
disruption. Indeed, this prediction is borneout in these crosses
(Fig. 6).
Thus, the data are consistent with the proposed model that
y2b cannot replace p. in promoting the completion of the
B cell developmental pathway. While y2b appears to mediate
feedback on endogenous H gene rearrangement, no B cells
emerge either in the bone marrow or in the spleen that ex-
press only y2b heavy chains. There is an absolute require-
ment for expression of lc in order for pre-B cells to complete
their development.
Why Is y2b Unable to Provide a Maturation Signal?
￿
One
function attributed to it chain expression is the induction
of L chain gene rearrangement (23, 31). An inability of y2b
to induce L gene rearrangement would be compatible with
the proposed model. B cells could develop to the pre-B cell
stage and would fail to progress past this stage in the absence
of a light chain. Evidence to support such a scenario comes
from studies with scidmice, which are defective in rearrange-
ment of Ig and TCR genes (32). They exhibit a block in
B cell development at a similar stage as wmem knockout mice
(26) . In the presence of a functional p, transgene, scid mice
develop normal pre-B cell populations, but very few B cells,
presumablydue to the inability to readily rearrange light chain
genes (33-35).
If y2b simply fails to induce light chain gene rearrange-ment, supplying a functionally rearranged light chain trans-
gene expressed in early pre-B cells should relieve the block
in B cell development and allow the productionof y2b-only
producing B cells at increased frequency in the periphery. How-
ever, X2 x y2b double transgenic mice do not exhibit an
increase in the efficiency of B cell production (Table 4). In
addition, all the B cells that populate the spleen express en-
dogenous a, similar to y2b-only transgenic mice.
Thus, the block in B cell development is not due to lack
oflight chain gene rearrangement. This conclusion is strength-
ened by the fact that no differences in fetal liver Kexpression
were observed between y2b transgenic mice and normal lit-
termates.
Others have recently obtained evidence that it is not re-
quired for the induction of light chain gene rearrangement
in pre-B cells (2, 29, 30, 36). However, in the presence of
A, L gene rearrangement seems to be upregulated (37). It
is intriguing to speculate that y2b may substitute for /. in
the upregulation of light chain gene rearrangement. Perhaps
the signals for cessation of heavy chain gene rearrangement,
which y can deliver and upregulation of light chain gene
rearrangement, are the same.
The signals for heavy chain gene rearrangement feedback
and B cell maturation apparently are different. The y2b mol-
ecule can only give the first Ig gene rearrangement feedback
signal that stops heavy chain gene rearrangement, but not
the B cell maturation signal, which it and S can deliver. Since
y2b appears capable of delivering a signal to stop H gene
rearrangement, but not a signal for B cell maturation, either
different regions ofthe heavychains are involved in the different
signals, or a given region of A can perform both functions,
whereas the analogous region of y2b can perform only one
function.
Structural differences between y2b proteins and I~ proteins
must be responsible for their functional differences. The most
obvious structural difference between u and y2b is the cyto-
plasmic tail (7) . However, the fact that the y2b-pmem trans-
genic mice exhibit an identical phenotype as the y2b trans-
genic mice argues that the IA transmembrane and cytoplasmic
tail regions are not sufficient to confer complete functional
competence onto a hybrid y2b-p, gene. It is possible that in
the context of the y2b-jAmem hybrid gene the W transmem-
brane and cytoplasmic domains may not fold into an appro-
priate three-dimensional structure. Alternatively, the trans-
membrane portion may be involved in the H gene feedback
only and the membrane domain of most heavychain isotypes
may be able to deliver this signal. The A and y proteins differ
no more in this protein domain than do P, and S (7), which
both can give a feedback as well as a maturation signal (4).
Notably, a tyr-ser doublet within the transmembrane por-
tion, which has been shown to be essential for signal trans-
duction and antigen presentation via mIgM (38), is present
in y2b at an identical position (7) .
Before the production of light chain, the heavy chain is
expressed in a pre-B cell receptor complex with the surrogate
light chains A5 and VpreB that is also capable of signal trans-
duction (39-42). The importance of this receptor is inferred
by the block in early B cell development observed in either
P.mem or A5 knockout mice (2, 29). However, X5 seemsnot
to be required for feedback inhibition of heavy chain gene
rearrangement in the few B cell that develop in X5 knockout
mice (29). In analogy, y2b may not require functional as-
sociation with X5 to cause H gene feedback. It is not known
whether y2b can combine with the surrogate light chains.
The association between X5 and j. heavy chains seems to occur
through the CH1 domain of it, as deletions of this domain
result in loss of association between /,4 and these polypep-
tides (43). Basedon the conservation ofBiP binding and light
chain binding to y2b via associations within the CH1 do-
main, it seems reasonable to expect that X5, which is struc-
turally similar to a light chain, may also associate with y2b
(44-47). However, even if y2b can bind X5, a correct signal
for B cell maturation may not be created.
mIg is expressed in the context of a cell surface receptor
in which the H and L chain polypeptides are associated with
Ig-a and Ig-(3 (48). It is known that all heavy chain isotypes
can associate with Ig-a and Ig-a (48-50). This receptor com-
plex participates in signal transduction events resulting from
engagement of mIg (51). In addition, multiple protein tyro-
sine kinases have been found to associate with mIg and to
be activated after crosslinking of the mIg receptor (52-54).
Many other target substrates havebeen identifieddownstream
from the mIgM receptor (55). It is likely that certain down-
stream signaling events may differ between IA- and -y-containing
Ig receptors.
The precise signal transduction mechanisms regulating the
normal progression of B cell development are beginning to
be elucidated. While a number of proteins associated with
the pre-B and B cell receptor have been identified, many have
not. It appears that y2b is unable to associate with or efficiently
transduce signals through all the pathways in which 1. can
participate. Further analysis ofthe y2b transgenic mice should
help to delineate the specific pathways downstream from heavy
chain expression that are required to complete B cell devel-
opment.
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